Vertex aims for triple combination to patients with cystic fibrosis
Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…
Pharmaceuticals, Biotechnology and Life Sciences
Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…
BASF Corporation is introducing Hepaxa, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease…
STA Pharmaceutical, a WuXi AppTec group company has entered into a deal with Regulus Therapeutics, an oligonucleotide synthesis collaboration agreement…
Celgene expects the transaction for Juno Therapeutics shares, to close in the first quarter of 2018. The company has said Wednesday…
Tetraphase Pharmaceuticals which creates antibiotics to treat life-threatening multidrug-resistant (MDR) infections, has gotten a licensing agreement with Everest Medicines Limited,…
CARB-X has announced its 2018 rounds of funding to support research into the development of antibiotics, vaccines, diagnostics, devices and…
Ritter Pharmaceuticals will seek to do make sure its first pivotal Phase 3 clinical trial of RP-G28 for lactose intolerance…
Hikma Pharmaceuticals has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer (CEO), who will also join Hikma’s Board of Directors…
Horizon Discovery’s CEO Darrin M. Disley has decided to step down to “pursue other business interests”. To replace him temporarily,…
Shire, Microsoft and EURORDIS-Rare Diseases Europe want to handle together with the diagnostic challenge for patients living with a rare…